The Efficacy of Decision Support E-book for Prostate Biopsy Decision Making
NCT03881709 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110
Last updated 2019-04-17
Summary
PURPOSE: This study is to test the efficacy of decision support E-Book for 1) increasing prostate biopsy knowledge and decision self-efficacy, and 2) reducing decisional conflict on prostate biopsy decision making in patients with elevated serum PSA.
DESIGN: The study is based on an experimental design. A convent sample of 110 adult males with a PSA greater than 4.0 ng/mL and the transrectal ultrasound-guided prostate biopsy suggested by a physician will be recruited from the urology clinics. Patients will be randomly assigned to the intervention and control group. The intervention group will receive the biopsy decision support intervention delivered by a nurse using an E-Book containing a comprehensive information about prostate biopsy. The control group will receive a health education about prostate biopsy. Data on biopsy knowledge, decision self-efficacy and decision conflict will be collected at pre and post test by using the study questionnaires.
ANALYSIS: Independent sample t -tests and chi-square tests will be used to compare the between group baseline equilibrium. Independent sample t -tests will be also used to analyze the between group differences in biopsy knowledge, decision self-efficacy, and decision conflict at post-test to evaluate the efficacy of the decision support intervention.
Conditions
- Prostate-Specific Antigen
Interventions
- BEHAVIORAL
-
Using an E-Book
The intervention group will receive the biopsy decision support intervention delivered by a nurse using an E-Book containing a comprehensive information about prostate biopsy.
Sponsors & Collaborators
-
Cheng-Hsin General Hospital
collaborator OTHER -
National Taipei University of Nursing and Health Sciences
lead OTHER
Principal Investigators
-
Tsae Jyy Wang, PhD · National Taipei University of Nursing and Health Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-04
- Primary Completion
- 2019-03-30
- Completion
- 2019-03-30
Countries
- Taiwan
Study Locations
More Related Trials
-
Early Staged Consent Before Prostate Biopsy
NCT03507725 ·Status: COMPLETED ·Phase: NA
-
Using Decision Analysis to Enhance Decision-Making Regarding Prostate Cancer Screening
NCT03387527 ·Status: COMPLETED ·Phase: NA
-
Shared Decision Making in Low Risk Prostate Cancer
NCT01673581 ·Status: WITHDRAWN
-
Multimedia-based Hormonal Therapy Information Program for Patients With Prostate Cancer
NCT04693910 ·Status: COMPLETED ·Phase: NA
-
Treatment Decision Making in Early-Stage Prostate Cancer
NCT00196781 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions
NCT03477591 ·Status: COMPLETED ·Phase: NA
-
A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values
NCT01553838 ·Status: COMPLETED ·Phase: NA
-
Promoting Shared-decision Making in Opportunistic Screening for Prostate Cancer
NCT05187949 ·Status: UNKNOWN
-
Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate Cancer
NCT06584279 ·Status: RECRUITING
-
Extended Systematic Versus Mri-Assisted pRostate Transperineal Biopsy
NCT04685928 ·Status: COMPLETED ·Phase: NA
-
The Application Research of Ultrasound Guided Puncture Stent Assisted Transperineal Prostate Biopsy
NCT05179720 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Prostate MRI Before Prostate Biopsies
NCT02485379 ·Status: COMPLETED ·Phase: NA
-
Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mL
NCT04317625 ·Status: UNKNOWN ·Phase: NA
-
Is it Feasible to Use Data Obtained Through a Three-Dimensional Reconstructed Image to Assist in Prostate Targeted Biopsy?
NCT07296510 ·Status: COMPLETED
-
Artificial Intelligence-Based Computer-Aided Diagnosis of Prostate Cancer
NCT05513638 ·Status: RECRUITING
-
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection
NCT03572946 ·Status: UNKNOWN ·Phase: NA
-
Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino Men
NCT00761124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis
NCT06589154 ·Status: COMPLETED
-
Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies
NCT04541030 ·Status: ACTIVE_NOT_RECRUITING
-
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
NCT06785441 ·Status: RECRUITING
-
Improving Decision-Making for Low Health Literate Prostate CA Patients
NCT05800483 ·Status: COMPLETED ·Phase: NA
-
Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer Screening
NCT04322045 ·Status: UNKNOWN ·Phase: NA
-
Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients
NCT00815750 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Mapping for Cognitive Prostate Biopsy
NCT05902637 ·Status: COMPLETED ·Phase: NA
-
Decision Support Interventions (DESI) for Prostate Cancer Screening - Study 1
NCT01241656 ·Status: COMPLETED ·Phase: NA